Long-term mortality among women with epithelial ovarian cancer: a population-based study in British Columbia, Canada

A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention

(2018) Gillian E. Hanley et al.   BMC CANCER

Prophylactic mastectomy for BRCA mutation carriers after ovarian cancer treatment: is it beneficial?

(2018) Joanne Kotsopoulos et al.   Expert Review of Anticancer Therapy

Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted?

(2017) Jacob McGee et al.   GYNECOLOGIC ONCOLOGY

Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)

(2017) Melissa Matz et al.   GYNECOLOGIC ONCOLOGY

The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)

(2017) Melissa Matz et al.   GYNECOLOGIC ONCOLOGY

Competing causes of death in the head and neck cancer population

(2017) Sean T. Massa et al.   ORAL ONCOLOGY

Ovarian carcinoma diagnosis: the clinical impact of 15 years of change

(2016) Stefan Kommoss et al.   BRITISH JOURNAL OF CANCER

Variation in causes of death in patients with non-small cell lung cancer according to stage and time since diagnosis

(2015) M. L. G. Janssen-Heijnen et al.   ANNALS OF ONCOLOGY

Causes of death in men with localized prostate cancer: a nationwide, population-based study

(2015) Mieke Van Hemelrijck et al.   BJU INTERNATIONAL

Long-term mortality among women with epithelial ovarian cancer

(2015) Helen E. Dinkelspiel et al.   GYNECOLOGIC ONCOLOGY

Lynch Syndrome in patients with clear cell and endometrioid cancers of the ovary

(2014) Koah R. Vierkoetter et al.   GYNECOLOGIC ONCOLOGY

Breast Cancer Following Ovarian Cancer inBRCAMutation Carriers

(2014) Alexandra Gangi et al.   JAMA Surgery

Ovarian carcinoma histotype determination is highly reproducible, and is improved through the use of immunohistochemistry

(2013) Martin Köbel et al.   HISTOPATHOLOGY

Germline BRCA1 and BRCA2 Mutations in Ovarian Cancer

(2012) Kasmintan A. Schrader et al.   OBSTETRICS AND GYNECOLOGY

Prognosis of Patients With Breast Cancer: Causes of Death and Effects of Time Since Diagnosis, Age, and Tumor Characteristics

(2011) Edoardo Colzani et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma

(2008) C. Blake Gilks et al.   HUMAN PATHOLOGY

Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies

(2008) Martin Köbel et al.   PLOS MEDICINE